We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Provides Guidance on Clinical Study Design for Opioid Use Disorder Devices
FDA Provides Guidance on Clinical Study Design for Opioid Use Disorder Devices
Recommendations for study design to facilitate innovation in development of devices, such as deep brain, transcranial magnetic and spinal cord stimulations, intended to treat opioid use disorder (OUD) are the subject of a draft guidance issued July 27.
